HGH Fragment 176-191
at the molecular level.
Targeted lipolysis.
No GH/IGF spillover.
Lipolytic GH Fragment · AOD analogue
Targeted lipolysis.
No GH/IGF spillover.
HGH Fragment 176-191 is the C-terminal region of human growth hormone, retaining the fat-reducing activity of the parent hormone while lacking its effects on insulin sensitivity or IGF-1 output. In research models it stimulates lipolysis and inhibits lipogenesis without binding the somatotropic axis, which is why it is studied as a metabolically selective fragment rather than a growth agonist.
Subcutaneous lyophilised formulation. Pharmacokinetic parameters validated by HPLC-MS at our Lausanne reference lab.
Every BIOHACKER batch ships with a third-party HPLC-MS certificate signed by the Lausanne reference lab.
No reviews yet. Be the first to document your research results.